Janux Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +116.7% | +769.2% | +644.2% | +132.5% | +5.4% | -1.5% | |
| – | +1,100.0% | +9,497.2% | +149.0% | +16.3% | +65.1% | +21.8% | |
| – | +742.3% | +234.9% | +155.2% | – | – | – | |
| – | – | +2,173.0% | -51.6% | -253.3% | – | +880.1% | |
| – | +0.0% | +0.0% | +334.9% | -71.3% | -80.6% | +190.5% | |
| – | +0.0% | +0.0% | – | -170.7% | +526.4% | +16.6% | |
| – | – | – | – | – | – | – | |
| – | -37.5% | +7,121.9% | -87.0% | – | – | – | |
| – | +188.1% | +3,254.1% | -99.9% | +11,809.6% | +1,097.7% | -99.3% | |
| – | +4,059.9% | +299.5% | -44.6% | -303.4% | – | -191.9% | |
| – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.